Ligand profile
CHEMBL464002
Bioactivity hit from ChEMBL on a similar protein.
Bound to: VK055_0532 — alpha/beta hydrolase fold family protein
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL464002- UniProt (similar protein)
P23141- pchembl
- 9.300 (~0.5 nM)
- Target protein
- VK055_0532
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 63.5
- −1 ≤ LogP ≤ 5 3.12
- MW ≤ 500 Da 318.4
- LogP ≤ 5 3.12
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 11
- TPSA ≤ 140 Ų 63.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCCCCCCCCC[S+]([O-])CC(O)(O)C(F)(F)FCCCCCCCCCC[S+]([O-])CC(O)(O)C(F)(F)F
InChI=1S/C13H25F3O3S/c1-2-3-4-5-6-7-8-9-10-20(19)11-12(17,18)13(14,15)16/h17-18H,2-11H2,1H3InChI=1S/C13H25F3O3S/c1-2-3-4-5-6-7-8-9-10-20(19)11-12(17,18)13(14,15)16/h17-18H,2-11H2,1H3
LMJSZIQYYOQSNX-UHFFFAOYSA-NLMJSZIQYYOQSNX-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Binding sites
- PF00135
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL464002 →
- UniProt UniProt P23141 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL464002”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0532.
PDB 17
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).